Search Results - "Lucas, Jose J."

Refine Results
  1. 1

    GSK3 and tau: two convergence points in Alzheimer's disease by Hernandez, Felix, Lucas, Jose J, Avila, Jesus

    Published in Journal of Alzheimer's disease (01-01-2013)
    “…Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that plays a key role in the pathogenesis of Alzheimer's disease (AD)…”
    Get more information
    Journal Article
  2. 2

    NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy by Gómez-Sintes, Raquel, Lucas, José J

    Published in The Journal of clinical investigation (01-07-2010)
    “…Use of lithium, the mainstay for treatment of bipolar disorder, is limited by its frequent neurological side effects and its risk for overdose-induced…”
    Get full text
    Journal Article
  3. 3

    Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3 by Engel, Tobias, Hernandez, Felix, Avila, Jesus, Lucas, Jose J

    Published in The Journal of neuroscience (10-05-2006)
    “…Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase that is particularly abundant in the CNS. Dysregulation of GSK-3…”
    Get full text
    Journal Article
  4. 4
  5. 5

    N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation by Goñi-Oliver, Paloma, Lucas, José J, Avila, Jesús, Hernández, Félix

    Published in The Journal of biological chemistry (03-08-2007)
    “…Although GSK-3 activity can be regulated by phosphorylation and through interaction with GSK-3-binding proteins, here we describe N-terminal proteolysis as a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Neuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependent by Gómez-Sintes, Raquel, Lucas, José J

    Published in PloS one (05-08-2013)
    “…Glycogen synthase kinase-3 (GSK-3) inhibitors have been postulated as useful therapeutic tools for the treatment of chronic neurodegenerative and…”
    Get full text
    Journal Article
  8. 8

    GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration by Gómez-Sintes, Raquel, Hernández, Félix, Lucas, José J, Avila, Jesús

    Published in Frontiers in molecular neuroscience (01-01-2011)
    “…Increased GSK-3 activity is believed to contribute to the etiology of chronic disorders like Alzheimer's disease (AD), schizophrenia, diabetes, and some types…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Impaired ATF6α processing, decreased Rheb and neuronal cell cycle re-entry in Huntington's disease by Fernandez-Fernandez, Maria Rosario, Ferrer, Isidro, Lucas, Jose J

    Published in Neurobiology of disease (01-01-2011)
    “…Abstract The endoplasmic reticulum-stress response is induced in several neurodegenerative diseases and in cellular models of Huntington's disease. However,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration by Engel, Tobias, Lucas, José J., Gómez-Ramos, Pilar, Moran, María A., Ávila, Jesús, Hernández, Félix

    Published in Neurobiology of aging (01-09-2006)
    “…Here we have tested whether tau modification either by point mutation or by hyperphosphorylation can exert maximal pathogenic effects or if, on the contrary,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Tau phosphorylation in hippocampus results in toxic gain-of-function by Avila, Jesús, Gómez de Barreda, Elena, Engel, Tobias, Lucas, Jose J, Hernández, Félix

    Published in Biochemical Society transactions (01-08-2010)
    “…The MAP (microtubule-associated protein) tau binds to tubulin, the main component of MTs (microtubules), which results in the stabilization of MT polymers. Tau…”
    Get more information
    Journal Article
  17. 17

    Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome by Hernández-Ortega, Karina, Garcia-Esparcia, Paula, Gil, Laura, Lucas, José J., Ferrer, Isidre

    Published in Brain pathology (Zurich, Switzerland) (01-09-2016)
    “…Ribosomes and protein synthesis have been reported to be altered in the cerebral cortex at advanced stages of Alzheimer's disease (AD). Modifications in the…”
    Get full text
    Journal Article
  18. 18

    Looking for novel functions of tau by Avila, Jesus, de Barreda, Elena Gomez, Fuster-Matanzo, Almudena, Simón, Diana, Llorens-Martín, María, Engel, Tobias, Lucas, Jose J, Díaz-Hernández, Miguel, Hernández, Félix

    Published in Biochemical Society transactions (01-08-2012)
    “…The lack or excess of the protein tau can be deleterious for neurons. The absence of tau can result in retarded neurogenesis and neuronal differentiation,…”
    Get more information
    Journal Article
  19. 19

    α-synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology by Corrochano, Silvia, Renna, Maurizio, Tomas-Zapico, Cristina, Brown, Steve D.M., Lucas, Jose J., Rubinsztein, David C., Acevedo-Arozena, Abraham

    Published in Autophagy (01-03-2012)
    “…Huntington and Parkinson diseases (HD and PD) are two major neurodegenerative disorders pathologically characterized by the accumulation of the aggregate-prone…”
    Get full text
    Journal Article
  20. 20

    Proteasomal Expression, Induction of Immunoproteasome Subunits, and Local MHC Class I Presentation in Myofibrillar Myopathy and Inclusion Body Myositis by FERRER, ISIDRO, MARTÍN, BEGOÑA, CASTAÑO, JOSÉ G, LUCAS, JOSÉ J, MORENO, DOLORES, OLIVÉ, MONTSE

    “…Inclusion body myositis (IBM) and myofibrillar myopathy (MM) are diseases characterized by the abnormal accumulation of proteins in muscle fibers, including…”
    Get full text
    Journal Article